| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 655305 | Null | 0.0238174255956144 | 0.40291535 |
| NSC 665522 | Null | 0.0238174255956144 | 0.42195659 |
| NSC 665622 | Cyclohexanone, 2,6-bis[(1-pyrrolidinyl)methyl]-, dihydrochloride | 0.0238174255956144 | 0.44534298 |
| NSC 669146 | 6,9-Epoxy-2H-1,4-dioxacyclodeca[cd]pentalene-2,7(4aH)-dione, 2a,3,5,6,11a,11b-hexahydro-3-hydroxy-2a,6,10-trimethyl-3-(1-methylethenyl)-, [2aS-(2aR*,3S*,4aR*,6S*,10Z,11aS*,11bS*)]- | 0.0238174255956144 | 0.1962131 |
| NSC 671190 | Null | 0.0238174255956144 | 0.47234781 |
| NSC 679796 | Null | 0.0238174255956144 | 0.19170445 |
| NSC 106486 | Formycin B | 0.024108502230778 | 0.061362232 |
| NSC 124764 | Methanesulfonic acid, thio-, S-hexadecyl ester (8CI) | 0.024108502230778 | 0.32926515 |
| NSC 295426 | Propanoic acid, 2-methyl-, 2,3,3a,4,5,8,9,11a-octahydro-6,10-bis(hydroxymethyl)-3-methylene-2-oxocyclodeca[b]furan-4-yl ester, [3aR-(3aR*,4S*,6Z,10Z,11aR*)]- (9CI) | 0.024108502230778 | 0.42175769 |
| NSC 349174 | Oxanthrazole | 0.024108502230778 | 0.055972193 |